Successful treatment of refractory neuro-Behçet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile
- 1 January 2007
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 66 (1) , 136-137
- https://doi.org/10.1136/ard.2006.056804
Abstract
A 36-year-old Japanese woman, already diagnosed as having Behçet’s disease on the basis of recurrent appearance of orogenital ulcers and bilateral uveitis, was referred to the First Department of Internal Medicine, Graduate School of Biochemical Sciences, Nagashaki University Hospital. On admission, neurological examinations showed cerebellar ataxia and pyramidal tract involvement. Examination of the patient’s cerebrospinal fluid (CSF) showed a total cell count of 576/mm3 with 56% neutrophils; protein was 128 mg/dl. A conventional therapeutic regimen, including intravenous methylprednisolone and cyclophosphamide and oral methotrexate, was used; however, she did not respond …Keywords
This publication has 8 references indexed in Scilit:
- Neuro-Behçet DiseaseThe Neurologist, 2005
- Successful treatment of long-standing neuro-Behçet's disease with infliximab.2005
- Cytokine production profile in patients with Behcet's disease treated with infliximabCytokine, 2003
- Anti-tumour necrosis factor α monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndromeAnnals of the Rheumatic Diseases, 2003
- The innate immune system in rheumatoid arthritisArthritis & Rheumatism, 2001
- Transcranial magnetic stimulation in Behçet's disease: a cross-sectional and longitudinal study with 44 patients comparing clinical, neuroradiological, somatosensory and brain-stem auditory evoked potential findingsClinical Neurophysiology, 2000
- Cytokine therapy in rheumatoid arthritisSpringer Seminars in Immunopathology, 1998